ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2790

Platelet Mediates Neutrophil Extracellular Traps Formation via TLR Signaling in ANCA-associated Vasculitis

Kotaro Matsumoto1, Hidekata Yasuoka 2, Katsuya Suzuki 1 and Tsutomu Takeuchi 1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine, Shinjuku-ku, Aichi, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Neutrophil Extracellular Traps, platelets and toll-like receptors, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T096: Vasculitis – ANCA-Associated II (2786–2791)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease that affects small- to medium-sized blood vessels and causes vascular inflammation and multiple organ damage. The pathogenesis of AAV is still unclear. However, neutrophil extracellular traps (NETs) is thought to be one of important triggers of vascular endothelial dysfunction in the disease process of AAV, and it is recently reported that platelets stimulated via toll-like receptor (TLR) pathways can induce NETs formation. Thus, platelets may be alternative key players in AAV pathogenesis. In this study, we investigated the role of platelets and involvement of TLR signaling in the process of NETs formation in patients with AAV.

Methods: Twenty-one patients with AAV (granulomatosis with polyangiitis [GPA]: n=12, microscopic polyangiitis [MPA]: n=9) who visited Keio University Hospital between August 2017 and October 2018 were consecutively enrolled. Ten SLE, 12 RA, and 20 healthy controls (HCs) were included as controls. All AAV patients fulfilled the 2012 Revised International Chapel Hill Consensus Conference Nomenclature. Expression of platelet-associated TLRs were examined using flow cytometry. Clinical information was obtained from patients’ record and association with expression of TLR was also examined. In order to examine functional involvement of platelets in NETs formation, platelets from AAV patients or HCs were co-cultured with peripheral neutrophils. In some experiments, platelets were stimulated with TLR agonist in advance. NETs formation visualized by Picogreen was detected and quantified using confocal fluorescent microscopy.

Results: As shown in the figure, platelets from AAV patients increased NETs formation compared with those from RA (p=0.0047), SLE (p=0.047) or HC (p=0.025). Flow cytometric analysis revealed that the expression of TLR9 (p=0.0011) but not other TLRs, such as TLR2 (p=0.71) and TLR4 (p=0.93), in platelets was elevated in platelets from AAV patients compared with HCs. In particular, the proportion of TLR9+platelets was elevated in patients with pulmonary involvement compared with those without (p=0.012), and was correlated with patients’ serum Krebs Von Den Lungen-6 level (r2=0.31, p=0.049). Interestingly, we found that TLR9 agonist (CpG oligodeoxynucleotides)-stimulated platelets from AAV patients induced NETs formation compared with control oligodeoxynucleotides-stimulated platelets.

Conclusion: These results suggest that platelets play a key role in NETs formation in the pathogenesis of AAV and TLR9 signaling is involved in this process.

Summary of DNA concentration from neutrophils induced by exposure to platelets from HC -n=20- and patients with AAV -n=21-, SLE -n=10- and RA -n=12-.


Disclosure: K. Matsumoto, None; H. Yasuoka, None; K. Suzuki, AbbVie, 2, Bristol-Myers Squibb, 2, Chugai, 2, Daiichi-Sankyo, 2, Eisai, 2, Fuji Film, 2, Kissei, 2, Mitsubishi Tanabe, 2, Ono, 2, Pfizer, 2, Takeda Pharmaceutical, 2; T. Takeuchi, Mitsubishi Tanabe Pharma Co., 2, 8, Mitsubishi Tanabe Pharma Corporation, 2, 5, 8.

To cite this abstract in AMA style:

Matsumoto K, Yasuoka H, Suzuki K, Takeuchi T. Platelet Mediates Neutrophil Extracellular Traps Formation via TLR Signaling in ANCA-associated Vasculitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/platelet-mediates-neutrophil-extracellular-traps-formation-via-tlr-signaling-in-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/platelet-mediates-neutrophil-extracellular-traps-formation-via-tlr-signaling-in-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology